Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Non-immune factors play a significant role in alopecia areata.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Betamethasone can effectively treat alopecia areata.

Corticosteroid injections helped eyebrow hair regrow in men with alopecia areata.

Vitamin D levels are not linked to alopecia areata.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Certain gene variations increase the risk of alopecia areata in Koreans.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.